investor.mirnarx.com
Investor Relations - Mirna TherapeuticsThe Investor Relations website contains information about Mirna Therapeutics business for stockholders, potential investors, and financial analysts.
http://investor.mirnarx.com/
The Investor Relations website contains information about Mirna Therapeutics business for stockholders, potential investors, and financial analysts.
http://investor.mirnarx.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Sunday
LOAD TIME
0.9 seconds
PAGES IN
THIS WEBSITE
18
SSL
EXTERNAL LINKS
13
SITE IP
206.200.251.19
LOAD TIME
0.937 sec
SCORE
6.2
Investor Relations - Mirna Therapeutics | investor.mirnarx.com Reviews
https://investor.mirnarx.com
The Investor Relations website contains information about Mirna Therapeutics business for stockholders, potential investors, and financial analysts.
investor.mirnarx.com
Mirna Therapeutics Reports Third Quarter 2016 Financial Results and MRX34 Clinical Program Updates (NASDAQ:MIRN)
http://investor.mirnarx.com/releasedetail.cfm?ReleaseID=998929
File is in Briefcase. Mirna Therapeutics Reports Third Quarter 2016 Financial Results and MRX34 Clinical Program Updates. Mirna Therapeutics, Inc. A biopharmaceutical company focused on microRNA-based oncology therapeutics, today reported financial results for the third quarter of 2016 and provided an update on recent developments. US Food and Drug Administration. Based on our assessment of both potential therapeutic benefit and risk, we have decided to discontinue development of MRX34 and suspend our pi...
Corporate Governance - Mirna Therapeutics
http://investor.mirnarx.com/corporate-governance.cfm
Clinical Trials and Pipeline. Annual Reports and Proxies. File is in Briefcase. File is in Briefcase. Nominating and Corporate Governance Committee Charter. File is in Briefcase. Code of Business Conduct and Ethics. File is in Briefcase. File is in Briefcase. Add file to Briefcase. Kelly France, Ph.D.
Mirna Therapeutics Company Update Call - Mirna Therapeutics
http://investor.mirnarx.com/eventdetail.cfm?EventID=175988
Clinical Trials and Pipeline. Annual Reports and Proxies. Mirna Therapeutics Company Update Call. Kelly France, Ph.D.
Investor Relations - Mirna Therapeutics
http://investor.mirnarx.com/index.cfm
Clinical Trials and Pipeline. Annual Reports and Proxies. Mirna Therapeutics Reports Third Quarter 2016 Financial Results and MRX34 Clinical Program Updates. Mirna Therapeutics Halts Phase 1 Clinical Study of MRX34. View all press releases ». 09-20-16 at 5:00 PM ET. Mirna Therapeutics Company Update Call. 09-13-16 at 10:25 AM ET. Rodman and Renshaw 18th Annual Global Investment Conference. View all events and presentations ». Kelly France, Ph.D.
Press Releases - Mirna Therapeutics
http://investor.mirnarx.com/releases.cfm
Clinical Trials and Pipeline. Annual Reports and Proxies. Mirna Therapeutics Reports Third Quarter 2016 Financial Results and MRX34 Clinical Program Updates. AUSTIN, Texas- (BUSINESS WIRE)- Mirna Therapeutics, Inc. (Nasdaq: MIRN), a biopharmaceutical company focused on microRNA-based oncology therapeutics, today reported financial results for the third quarter of 2016 and provided an update on recent developments. MRX34 CLINICAL PROGRAM . File is in Briefcase. File is in Briefcase. File is in Briefcase.
TOTAL PAGES IN THIS WEBSITE
18
Во что вложить деньги в 2015, во что стоит вкладывать деньги
Бесплатный звонок по России:. Процентная ставка при досрочном востребовании: 12%. ИНВЕСТИЦИОННАЯ ПРОГРАММА КОМПАНИИ МИКРОКЛАД. МИКРОКЛАД 9 МЕСЯЦЕВ РОСТА. Высокий доход от инвестиций. Финансовая организация Микроклад предлагает Вам разместить вклад под 24 % годовых. Законность и надежность нашего предложения регламентируется Федеральным Законом 151 О микрофинансовой деятельности и микрофинансовых организациях от 04 января 2011 года. Норматив достаточности собственных средств фирмы, рассчитанный по формуле...
Microsemi Corporation InvestorRoom - Investor Relations
Drivers, Interfaces, and PCIe Switches. Ethernet and PoE Solutions. Power Discretes and Modules. RF, Microwave and Millimeter Wave. PDS-EM-8100 2.5Gbps NBASE-T PoE Mux. Optimal solution for 802.11ac wave II 2.5G Access points. Upgrades existing 1G switch to 2.5G interface. 2 x 1G ports , 1 x 2.5G port with 30W PoE. Plug and Play zero configuration. Advanced Driver Assist Systems (ADAS). Powertrain and EV Charging. Aviation Center Of Excellence. Engine Systems and Controls. RF and Microwave Systems. Micro...
investor.micrusendovascular.com
DOMAIN ERROR
Takeda Oncology | 2017 News Releases
Our People and Culture. 1000 Cranes of Hope. Sunshine Act / Open Payments Program. Preclinical Drug Compound Request Program. Access to Investigational Medicines. We Aspire to Cure Cancer. Our People and Culture. Global Oncology Leadership Team. 1000 Cranes of Hope. Sunshine Act / Open Payments Program. Preclinical Drug Compound Request Program. Access to Investigational Medicines. Our People and Culture. 1000 Cranes of Hope. Sunshine Act / Open Payments Program. Preclinical Drug Compound Request Program.
Investor relations – Minesto
Power from Tidal and Ocean Currents. Low cost of energy. Simple and robust design. Causes no visual impact. Only small vessels required. Efficient in low velocity currents. Pressmeddelanden och rapporter via E-post. VD Martin Edlund presenterar Minesto på Stora Aktiedagen i Göteborg, arrangerad av Aktiespararna. Minesto flyger drake i TV4Nyheterna. Senare höjdes ribban genom att vi fick vara med i TV4Nyheterna ett fantastiskt PR-tillfälle för ett litet företag som Minesto. On Tuesday, Minesto attended th...
Investor Relations - Mirna Therapeutics
Clinical Trials and Pipeline. Annual Reports and Proxies. Mirna Therapeutics Reports Third Quarter 2016 Financial Results and MRX34 Clinical Program Updates. Mirna Therapeutics Halts Phase 1 Clinical Study of MRX34. View all press releases ». 09-20-16 at 5:00 PM ET. Mirna Therapeutics Company Update Call. 09-13-16 at 10:25 AM ET. Rodman and Renshaw 18th Annual Global Investment Conference. View all events and presentations ». Kelly France, Ph.D.
Investors | Mitel Networks Corporation
Skip to main navigation. Return to Mitel.com. Feb 27, 2018 8:00 AM ET. Watch the Videos from Mitel Next in San Antonio June 2017. Giving a Voice to Digital Transformation. Get answers to frequently asked investor questions. Michael W. McCarthy. Vice President, Investor Relations. 1 800 522 6645. Mar 22, 2018. Mitel Announces Definitive Agreement to Sell DeTeWe to German ICT Systems Integrator Ostertag Group. Mar 15, 2018. Mar 13, 2018. Apr 26, 2018 at 10:00 AM EDT. Mar 29, 2018. Mar 26, 2018. Mar 15, 2018.
M.K. Real Estate Development Public Company Limited
Affidavit and Articles of Association. Keep yourself updated with our latest news. Welcome to Investor Relations. MK Real Estate Development Public Company Limited is in the business of property development, construction and property rental. Our focus is on low-rise residential project. 18 Projects comprising single-detached house and duplex. Under the brand name Chuan Chuen and Serene House . Our properties for rental include office building and sports clubs. Notification of the resignation of director.
MK Restaurant : Thailand MK Suki Restaurant - ช่วงเวลาแห่งความอบอุ่น
3594;่วงเวลา.แห่งความอบอุ่น. 3627;น้าแรก. Bull; MK History. Bull; Success Awards. Bull; Training Center. Bull; Corporate Information. Bull; Financial Information. Bull; Stock Information. Bull; Shareholder Information. Bull; Corporate Governance. Bull; Corporate Social Resposibility. Bull; Publication and Download. Bull; Webcast and Presentation. Bull; Analyst Coverage. Bull; Information Request. Bull; Menu in Restaurant. Bull; Online Delivery. Welcome to Investor Relations. Updated: 12 Jan 2017 16:37.
Investor Relations | MKS Instruments, Inc.
Skip to main navigation. We work with customers across four major industries to develop solutions to their toughest Process and production challenges. All of our customers use sophisticated advanced technology in their processes. They rely on MKS Instruments' broad portfolio of innovative instruments, components, subsystems and software to solve their problems. Select an industry below to learn more about how we can help you succeed:. Environmental Monitoring, Defense and Security. We work with customers...
Takeda Oncology | 2017 News Releases
Our People and Culture. 1000 Cranes of Hope. Sunshine Act / Open Payments Program. Preclinical Drug Compound Request Program. Access to Investigational Medicines. We Aspire to Cure Cancer. Our People and Culture. Global Oncology Leadership Team. 1000 Cranes of Hope. Sunshine Act / Open Payments Program. Preclinical Drug Compound Request Program. Access to Investigational Medicines. Our People and Culture. 1000 Cranes of Hope. Sunshine Act / Open Payments Program. Preclinical Drug Compound Request Program.
